Male prevalence of acquired color vision defects in asymptomatic carriers of Leber's hereditary optic neuropathy

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 5, 2007, Pages 2362-2370

  Ventura, Dora Fix ^a   Gualtieri, Mirella ^a   Oliveira, André G F ^a   Costa, Marcelo F ^a   Quiros, Peter ^b   Sadun, Federico ^c   De Negri, Anna Maria ^d   Salomão, Solange R ^e   Berezovsky, Adriana ^e   Sherman, Jerome ^f   Sadun, Alfredo A ^b   Carelli, Valerio ^b,g  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^e FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^f STATE UNIVERSITY OF NEW YORK   (United States)

^g UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; COLOR VISION DEFECT; CONTROLLED STUDY; DIAGNOSTIC TEST; EYE EXAMINATION; FEMALE; GENE MUTATION; GENETIC DISORDER; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; MONOCULAR DEPRIVATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETINA CONE; SEX DIFFERENCE; VISUAL IMPAIRMENT; BRAZIL; COLOR VISION TEST; GENETICS; HETEROZYGOTE DETECTION; MIDDLE AGED; OBSERVER VARIATION; PEDIGREE; POINT MUTATION; PREVALENCE; REPRODUCIBILITY;

MITOCHONDRIAL DNA;

ADULT; BRAZIL; COLOR PERCEPTION TESTS; COLOR VISION DEFECTS; DNA, MITOCHONDRIAL; FEMALE; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; OPTIC ATROPHY, HEREDITARY, LEBER; PEDIGREE; POINT MUTATION; PREVALENCE; REPRODUCIBILITY OF RESULTS; SEX FACTORS;

EID: 34250175807     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0331     Document Type: Article

References (52)

1. Newman NJ. Leber's optic neuropathy. In: Miller NR, Newman NJ, Valerie B, Kerrison JB, eds. Walsh and Hoyt's Clinical Neuro-Ophthalmology Baltimore: Lippincott Williams & Wilkins; 2005: 466-476.
2. Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23:53-89.
3. Wallace DC, Singh G, Lott MT, et al. Mitochondrial-DNA mutation associated with Leber's hereditary optic neuropathy. Science. 1988;242:1427-1430.
4. Howell N. Leber hereditary optic neuropathy: respiratory chain dysfunction and degeneration of the optic nerve. Vision Res. 1998;38:1495-1504.
5. Riordaneva P, Harding AE. Lebers hereditary optic neuropathy: the clinical relevance of different mitochondrial-DNA mutations. Med Genet. 1995;32:81-87.
6. Tsao K, Aitken PA, Johns DR. Smoking as an aetiological factor in a pedigree with Leber's hereditary optic neuropathy. Br J Ophthalmol. 1999;83:577-581.
7. Kerrison JB, Miller NR, Hsu FC, et al. A case-control study of tobacco and alcohol consumption in Leber hereditary optic neuropathy. Am J Ophthalmol. 2000;130:803-812.
8. Sadun AA, Carelli V, Salomao SR, et al. Extensive investigation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol. 2003;136:231-238.
9. Carelli V, Giordano C, d'Amati G. Pathogenic expression of homoplasmic mtDNA mutations needs a complex nuclear-mitochondrial interaction. Trends Genet. 2003;19:257-262.
10. Ventura DF, Quiros P, Carelli V, et al. Chromatic and luminance contrast sensitivities in asymptomatic carriers from a large Brazilian pedigree of 11778 Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci. 2005;46:4809-4814.
11. Quiros PA, Torres RJ, Salomao S, et al. Colour vision defects in asymptomatic carriers of the Leber's hereditary optic neuropathy (LHON) mtDNA 11778 mutation from a large Brazilian LHON pedigree: a case-control study. Br J Ophthalmol. 2006;90:150-153.
12. Sadun F, de Negri AM, Carelli V, et al. Ophthalmologic findings in a large pedigree of 11778/Haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol. 2004;137:271-277.
13. Savini G, Barboni P, Valentino ML, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations. Opthalmology. 2005;112:127-131.
14. Pokorny J, Bowen RW, Williams DT, Smith VC. Duration thresholds for chromatic stimuli. In: Congenital and Acquired Color Vision Defects. New York: Grune & Stratton; 1979:103-106.
15. Birch J. Diagnosis of Defective Colour Vision. 2nd ed. Boston: Butterworth-Heinemann Medical; 2001.
16. Grigsby SS, Vingrys AJ, Benes SC, King-Smith PE. Correlation of chromatic, spatial, and temporal sensitivity in optic nerve disease. Invest Ophthalmol Vis Sci. 1991;32:3252-3262.
17. Nikoskelainen E, Hoyt WF, Nummelin K. Ophthalmoscopic findings in Lebers hereditary optic neuropathy. 1. Fundus findings in asymptomatic family members. Arch Ophthalmol. 1982;100: 1597-1602.
18. Carroll WM, Mastaglia FL. Lebers optic neuropathy Clinical and visual evoked-potential study of affected and asymptomatic members of a 6 generation family. Brain. 1979;102:559-580.
19. Livingstone IR, Mastaglia FL, Howe JW, Aherne GES. Leber optic neuropathy: clinical and visual evoked-response studies in asymptomatic and symptomatic members of a 4-generation family. Br J Ophthalmol. 1980;64:751-757.
20. Stehouwer A, Went LN. Lebers Optic Neuropathy. 1. Clinical-studies. Doc Ophthalmol. 1982;53:97-111.
21. Regan BC, Reffin JP, Mollon JD. Luminance noise and the rapid-determination of discrimination ellipses in color deficiency. Vision Res. 1994;34:1279-1299.
22. Ventura DF, Silveira LCL, Rodrigues AR, et al. Preliminary norms for the Cambridge Colour Test. In: Mollon JD, Pokorny J, Knoblauch K, eds. Normal and Defective Colour Vision. New York: Oxford University Press; 2003:331-339.
23. Ventura DF, Simoes AL, Tomaz S, et al. Colour vision and contrast sensitivity losses of mercury intoxicated industry workers in Brazil. Environ Toxicol Pharmacol. 2005;19:523-529.
24. Derrington AM, Krauskopf J, Lennie P. Chromatic mechanisms in lateral geniculate nucleus of macaque. J Physiol. 1984;357:241-265.
25. Lee BB, Valberg A, Tigwell DA, Tryti, J. An account of responses of spectrally opponent neurons in macaque lateral geniculate nucleus to successive contrast. Proc R Soc Lond B. 1987;230:293-314.
26. Valberg A, Lee BB, Tryti J. Simulation of responses of spectrally opponent neurones in the macaque lateral geniculate nucleus to chromatic and achromatic light stimuli. Vision Res. 1987;27:867-882.
27. Carelli V, Achilli A, Valentino ML, et al. Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees. Am J Hum Genet. 2006;78:564-574.
28. Chylack LT, Leske MC, McCarthy D, Khu P, Kashiwagi T, Sperduto R. Lens Opacities Classification System-Ii (LOCS-II). Arch Ophthalmol. 1989;107:991-997.
29. Ferris FL, Kassoff A, Bresnick GH, Bailey I. New visual-acuity charts for clinical research. Am J Ophthalmol. 1982;94:91-96.
30. Castelo-Branco M, Faria P, Forjaz V, Kozak LR, Azevedo H. Simultaneous comparison of relative damage to chromatic pathways in ocular hypertension and glaucoma: correlation with clinical measures. Invest Ophthalmol Vis Sci 2004;45:499-505.
31. Regan BC, Freudenthaler N, Kolle R, Mollon JD, Paulus W. Colour discrimination thresholds in Parkinson's disease: results obtained with a rapid computer-controlled colour vision test. Vision Res. 1998;38:3427-3431.
32. Silva MF, Faria P, Regateiro FS, et al. Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson's disease. Brain. 2005;128:2260-2271.
33. Simunovic MP, Votruba M, Regan BC, Mollon JD. Colour discrimination ellipses in patients with dominant optic atrophy. Vision Res. 1998;38:3413-3419.
34. Ventura DF, Costa MF, Gualtieri M, et al. Early vision loss in diabetic patients assessed by the Cambridge Colour Test. In: Mollon JD, Pokorny J, Knoblauch K, eds. Normal and Defective Colour Vision. New York: Oxford University Press; 2003:395-408.
35. Ventura DF, Silveira LCL, Nishi M, et al. Color vision loss in patients treated with chloroquine. Arq Bras Oftalmol. 2003;66:9-15.
36. Ventura DF, Costa MTV, Costa MF, et al. Multifocal and full-field electroretinogram changes associated with color-vision loss in mercury vapor exposure. Vis Neurosci. 2004;21:421-429.
37. Costa MF, Ventura DF, Perazzolo F, Murakoshi MT, Silveira LCL. Absence of binocular summation, eye dominance and learning effects in color discrimination. Vis Neurosci. 2006;23:461-469.
38. Knoblauch K, Vital-Durand F, Barbur JL. Variation of chromatic sensitivity across the life span. Vision Res. 2001;41:23-36.
39. Smith VC, Pokorny J, Pass AS. Color-axis determination on the Farnsworth-Munsell 100-Hue Test. Am J Ophthalmol. 1985;100: 176-182.
40. Verriest G, Vanlaethem J, Uvijls A. A new assessment of the normal ranges of the Farnsworth-Munsell 100-Hue test-scores. Am J Ophthalmol. 1982;93:635-642.
41. Sadun AA, Win PH, Ross-Cisneros FN, Walker SO, Carelli V. Leber's hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans Am Ophthalmol Soc. 2000;98:223-235.
42. Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int. 2002;40:573-584.
43. Sadun AA. Optic neuropathies and retinal ganglion cell death. Neuroophthalmology. 2000;24:387-394.
44. Lee BB, Sun H. Chromatic input to cells of the magnocellular pathway: Mean chromaticity and the relative phase of modulated lights. Vis Neurosci. 2004;21:309-314.
45. Pokorny J, Smith VC. Eye disease and color defects. Vision Res. 1986;26:1573-1584.
46. Dacey DM, Packer OS. Colour coding in the primate retina: diverse cell types and cone-specific circuitry. Curr Opin Neurobiol. 2003; 13:421-427.
47. Bu XD, Rotter JI. X-Chromosome-linked and mitochondrial gene-control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X-chromosome inactivation. Proc Natl Acad Sci USA. 1991;88:8198-8202.
48. Chalmers RM, Davis MB, Sweeney MG, Wood NW, Harding AE. Evidence against an X-linked visual loss susceptibility locus in Leber hereditary optic neuropathy. Am J Hum Genet. 1996;59: 103-108.
49. Hudson G, Keers S, Man PYW, et al. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am J Hum Genet. 2005;77:1086-1091.
50. Beretta S, Mattavelli L, Sala G, et al. Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines. Brain. 2004;127:2183-2192.
51. Floreani M, Napoli E, Martinuzzi A, et al. Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber's hereditary optic neuropathy. FEBS Lett. 2005;272:1124-1135.
52. Borras C, Sastre J, Garcia-Sala D, Lloret A, Pallardo FV, Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med. 2003;34:546-552.